Loading…

MilliporeSigma signed a commercial supply agreement to manufacture lentiviral vectors for bluebird bio's gene therapies for rare genetic diseases. The multi-year agreement covers manufacturing at MilliporeSigma's Carlsbad, California facility.
“We look forward to collaborating with bluebird bio to bring to market breakthrough therapies to fight diseases for which there are limited or no options.”prnewswire.com
Summarized from public sources; check the original articles before acting on it.